StockNews.AI
VEEV
StockNews.AI
105 days

Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit

1. Veeva's keynote at 2025 Commercial Summit highlights AI integration in products. 2. Prominent firms will discuss strategies for coordinated customer engagement. 3. Veeva aims to enhance data-driven marketing and sales solutions. 4. Industry leaders are focusing on interconnected customer experiences. 5. Veeva is a key player in cloud software for life sciences.

6m saved
Insight
Article

FAQ

Why Bullish?

The focus on AI integration reflects growing demand in life sciences, similar to past trends seen at key industry conferences, which historically boosted VEEV’s stock performance.

How important is it?

The announcement underlines significant industry engagement and potential market expansion avenues for Veeva, likely influencing investor sentiment positively.

Why Long Term?

The strategic advancements and industry collaboration reported will likely support long-term growth, as seen in previous initiatives that significantly improved Veeva's market position.

Related Companies

AZNBAYNLLYJNJMDGL
AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, and more share strategies for more connected customer experiences across sales, marketing, and medical , /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its keynote speakers for the 2025 Veeva Commercial Summit, May 13-14 in Boston. Leading and emerging biopharmas will share innovations and strategies to drive more coordinated customer engagement through effective use of AI and alignment across data, content, and teams. Veeva CEO Peter Gassner will headline the opening keynote, sharing Veeva's major initiative to add AI to the Vault Platform and Veeva applications, including ongoing innovations across Veeva Commercial Cloud and Veeva Data Cloud. Keynote presenters will include experiences from: AstraZeneca standardizing analytics across its brands to boost marketing reach and performance. Bayer driving customer-centric, coordinated engagement with Vault CRM. Boehringer Ingelheim connecting scientific insights across medical to drive effective, personalized key opinion leader conversations. Lilly integrating its content ecosystem by streamlining workflows, standardizing taxonomy, and aligning global teams to deliver high-impact experiences at scale. Johnson & Johnson and Madrigal each building a modern data foundation with connected insights for greater efficiency and field impact. ANI Pharmaceuticals, Gamida Cell, NewAmsterdam Pharma, Orchard Therapeutics, Sobi, and others will also share go-to-market best practices for emerging biotechs at launch and beyond.  "By connecting sales, marketing, and medical, field teams can seamlessly work together to drive more effective, customer-centric experiences," said Matt Farrell, president of Veeva Commercial Cloud. "We're excited to bring the industry together to share ideas and advancements in AI and data and help lead this next phase of unified engagement." Veeva Commercial Summit is one of the largest industry events in North America for commercial and medical affairs leaders. Life sciences industry professionals can register and see the full agenda at veeva.com/Summit. About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com. Veeva Forward-looking StatementsThis release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at sec.gov. Contact: Matilde Macieira-KaufmannVeeva Systems925-226-8821[email protected] SOURCE Veeva Systems WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News